305 related articles for article (PubMed ID: 18001502)
1. Proteinases in the joint: clinical relevance of proteinases in joint destruction.
Rengel Y; Ospelt C; Gay S
Arthritis Res Ther; 2007; 9(5):221. PubMed ID: 18001502
[TBL] [Abstract][Full Text] [Related]
2. Understanding the role of tissue degrading enzymes and their inhibitors in development and disease.
Cawston TE; Wilson AJ
Best Pract Res Clin Rheumatol; 2006 Oct; 20(5):983-1002. PubMed ID: 16980219
[TBL] [Abstract][Full Text] [Related]
3. The clinical potential of matrix metalloproteinase inhibitors in the rheumatic disorders.
Elliott S; Cawston T
Drugs Aging; 2001; 18(2):87-99. PubMed ID: 11346130
[TBL] [Abstract][Full Text] [Related]
4. Matrix Metalloproteinases and Synovial Joint Pathology.
Malemud CJ
Prog Mol Biol Transl Sci; 2017; 148():305-325. PubMed ID: 28662824
[TBL] [Abstract][Full Text] [Related]
5. Matrix metalloproteinases and tissue inhibitors of metalloproteinases in synovial fluids from patients with rheumatoid arthritis or osteoarthritis.
Yoshihara Y; Nakamura H; Obata K; Yamada H; Hayakawa T; Fujikawa K; Okada Y
Ann Rheum Dis; 2000 Jun; 59(6):455-61. PubMed ID: 10834863
[TBL] [Abstract][Full Text] [Related]
6. Profile of Matrix-Remodeling Proteinases in Osteoarthritis: Impact of Fibronectin.
Pérez-García S; Carrión M; Gutiérrez-Cañas I; Villanueva-Romero R; Castro D; Martínez C; González-Álvaro I; Blanco FJ; Juarranz Y; Gomariz RP
Cells; 2019 Dec; 9(1):. PubMed ID: 31877874
[TBL] [Abstract][Full Text] [Related]
7. Pathogenesis of joint destruction in rheumatoid arthritis.
Shiozawa S; Tsumiyama K; Yoshida K; Hashiramoto A
Arch Immunol Ther Exp (Warsz); 2011 Apr; 59(2):89-95. PubMed ID: 21327737
[TBL] [Abstract][Full Text] [Related]
8. Metalloproteinases in Rheumatoid Arthritis: Potential Therapeutic Targets to Improve Current Therapies.
Itoh Y
Prog Mol Biol Transl Sci; 2017; 148():327-338. PubMed ID: 28662826
[TBL] [Abstract][Full Text] [Related]
9. Basic calcium phosphate crystals: pathways to joint degeneration.
Molloy ES; McCarthy GM
Curr Opin Rheumatol; 2006 Mar; 18(2):187-92. PubMed ID: 16462527
[TBL] [Abstract][Full Text] [Related]
10. Matrix metalloproteinases: role in arthritis.
Burrage PS; Mix KS; Brinckerhoff CE
Front Biosci; 2006 Jan; 11():529-43. PubMed ID: 16146751
[TBL] [Abstract][Full Text] [Related]
11. Matrix metalloproteinase knockout studies and the potential use of matrix metalloproteinase inhibitors in the rheumatic diseases.
Milner JM; Cawston TE
Curr Drug Targets Inflamm Allergy; 2005 Jun; 4(3):363-75. PubMed ID: 16101546
[TBL] [Abstract][Full Text] [Related]
12. [Cartilage degradation in rheumatoid arthritis].
Ishiguro N
Clin Calcium; 2009 Mar; 19(3):347-54. PubMed ID: 19252244
[TBL] [Abstract][Full Text] [Related]
13. Metalloproteinase inhibitors and the prevention of connective tissue breakdown.
Cawston TE
Pharmacol Ther; 1996; 70(3):163-82. PubMed ID: 8888065
[TBL] [Abstract][Full Text] [Related]
14. Local overexpression of adeno-viral IL-4 protects cartilage from metallo proteinase-induced destruction during immune complex-mediated arthritis by preventing activation of pro-MMPs.
van Lent PL; Holthuysen AE; Slöetjes A; Lubberts E; van den Berg WB
Osteoarthritis Cartilage; 2002 Mar; 10(3):234-43. PubMed ID: 11869085
[TBL] [Abstract][Full Text] [Related]
15. Matrix metalloproteinases and TIMPs: properties and implications for the rheumatic diseases.
Cawston T
Mol Med Today; 1998 Mar; 4(3):130-7. PubMed ID: 9575496
[TBL] [Abstract][Full Text] [Related]
16. Clinical implications of matrix metalloproteinases.
Mandal M; Mandal A; Das S; Chakraborti T; Sajal C
Mol Cell Biochem; 2003 Oct; 252(1-2):305-29. PubMed ID: 14577606
[TBL] [Abstract][Full Text] [Related]
17. Complementary action of granulocyte macrophage colony-stimulating factor and interleukin-17A induces interleukin-23, receptor activator of nuclear factor-κB ligand, and matrix metalloproteinases and drives bone and cartilage pathology in experimental arthritis: rationale for combination therapy in rheumatoid arthritis.
van Nieuwenhuijze AE; van de Loo FA; Walgreen B; Bennink M; Helsen M; van den Bersselaar L; Wicks IP; van den Berg WB; Koenders MI
Arthritis Res Ther; 2015 Jun; 17(1):163. PubMed ID: 26081345
[TBL] [Abstract][Full Text] [Related]
18. Adenoviral gene transfer of interleukin-1 in combination with oncostatin M induces significant joint damage in a murine model.
Rowan AD; Hui W; Cawston TE; Richards CD
Am J Pathol; 2003 Jun; 162(6):1975-84. PubMed ID: 12759253
[TBL] [Abstract][Full Text] [Related]
19. Proteinases and their receptors in inflammatory arthritis: an overview.
Oikonomopoulou K; Diamandis EP; Hollenberg MD; Chandran V
Nat Rev Rheumatol; 2018 Mar; 14(3):170-180. PubMed ID: 29416136
[TBL] [Abstract][Full Text] [Related]
20. The paradox of matrix metalloproteinases in infectious disease.
Elkington PT; O'Kane CM; Friedland JS
Clin Exp Immunol; 2005 Oct; 142(1):12-20. PubMed ID: 16178851
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
